- Joined
- Sep 16, 2006
- Messages
- 127
- Reaction score
- 1
Been quite some time since I've posted, but I'm curious what others might have experienced here. I am a partner in a private pathology group that has an exclusive contract with a hospital system. We are responsible for everything that happens in our system. Within the past 2 years, this hospital system has hired 2 dermatologists; fully employed by the hospital. We are a 4 1/2 pathologist group and none of us are a boarded dermatopathologist. I am the youngest partner, 5 years working, but most of my partners have been working for >20 years. Prior to the hiring of these dermatologists, we saw a decent amount of derm from our plastic and general surgeons, as well as a smattering from our primary care offices. Now, we see a lot more. Two of us (me included) have more than the usual amount of dermpath training, and feel quite comfortable in this area. To our knowledge, we have never had a significant miss...i.e., we have never missed a melanoma. Nonetheless, our dermatologists do not trust us at all when it comes to melanocytic lesions. They distrust us "a priori", because we are not boarded dermatopathologists. This has created an enormous problem for us, the dermatologists, and the hospital. As a result, we are being forced to send out much of what we call dysplastic nevi for second opinion. Specifically, anything we call "moderate" and above. Our dermpath consultant agrees with us in essentially every case, but this does not change the opinion of our dermatologists for reasons beyond me and the scope of this post. The send outs create an enormous burden for our administrative assistants, as well as us. It's also an infuriating imposition to have so many cases subject to outside review. Our dermatologists would like to be able to directly send pigmented lesions to a dermpath lab of their choosing.
Editorial comment: Personally, I have come to question this part of practice of dermatology. The incidence of melanoma has increased dramatically over the past decades, but death rates have remained constant. Are we really doing anyone a service in how we interpret nevi? This seems similar to the preoccupation with "premalignant" lesions elsewhere, such as low-grade DCIS...end editorial comment...
More practically, I am curious if anyone else has been in a similar situation. Is anyone else in a system with employed dermatologists, but no dermpath? How do you handle this? How has it affected you?
Editorial comment: Personally, I have come to question this part of practice of dermatology. The incidence of melanoma has increased dramatically over the past decades, but death rates have remained constant. Are we really doing anyone a service in how we interpret nevi? This seems similar to the preoccupation with "premalignant" lesions elsewhere, such as low-grade DCIS...end editorial comment...
More practically, I am curious if anyone else has been in a similar situation. Is anyone else in a system with employed dermatologists, but no dermpath? How do you handle this? How has it affected you?